Here’s a bold statement for you: Michael King could be the most intriguing yet polarizing free agent pitcher on the market right now. But here’s where it gets controversial—while he’s arguably a top-10 arm in MLB when healthy, his recent injury history has teams and fans alike scratching their heads. Is he worth the risk? Let’s dive in.
Michael King, whose stats you can explore further here, is a high-reward, high-risk prospect in the starting pitching class. His talent is undeniable—when healthy, he’s a dominant force on the mound. But his 2025 season was cut short by a nerve injury in his throwing shoulder, leaving many to wonder if he can stay on the field consistently. Adding to the complexity, King is tied to draft compensation after turning down a qualifying offer from the Padres. And this is the part most people miss—despite these red flags, numerous teams are still circling, eager to land his services.
The Cubs, Tigers, and Yankees have long been linked to King, and even the Marlins have thrown their hat in the ring as a long-shot contender. According to Mark Feinsand of MLB.com, the Mets, Orioles, Angels, and Padres are also lurking on the periphery. Joel Sherman of The New York Post adds the Red Sox to the list of suitors for the 30-year-old right-hander. But why all the interest in a pitcher with such a shaky injury history?
King’s potential is undeniable. After transitioning to the starting rotation late in the 2023 season with the Yankees, he thrived in San Diego, finishing seventh in NL Cy Young voting in 2024 with a stellar 2.95 ERA and 201 strikeouts over 31 appearances. His 2025 campaign started even hotter, with a 2.59 ERA and a 28% strikeout rate over his first 10 starts before the injury derailed his season. But here’s the kicker—durability is his Achilles’ heel. While the shoulder injury wasn’t structural, it sidelined him for nearly three months, and his return late in the season was underwhelming. In five starts, he gave up 12 runs in just 17 1/3 innings, with only 12 strikeouts and nine walks. His velocity was fine, but the command and consistency were missing.
This raises a critical question: Can King stay healthy long enough to justify a lucrative contract? Before the injury, he was on track for a nine-figure deal. Now, that seems less likely, especially since 2024 remains the only season in which he’s surpassed 105 innings. His injury history—including a finger injury in 2021 and a season-ending elbow fracture in 2022—doesn’t help his case. MLBTR predicts he’ll land a four-year, $80MM deal, but King might prefer a shorter contract with an opt-out clause to test free agency again next winter. Jeff Passan of ESPN reports that King is open to a shorter term than top free agents like Framber Valdez or Ranger Suárez, though a four-year deal isn’t off the table.
Teams like the Mets, who desperately need a mid-rotation or better arm after their rotation collapsed in the second half of 2025, could be a perfect fit. The Orioles, Angels, and Padres are also in the mix, though San Diego may not be willing to spend what it takes to bring King back. Here’s a thought-provoking question for you—is King’s upside worth the risk, or should teams prioritize more reliable options?
The Red Sox, after acquiring Sonny Gray and Johan Oviedo, might shift their focus elsewhere, while the Angels, despite adding Grayson Rodriguez and Alek Manoah, still need a starter and are eyeing Zac Gallen. The Orioles, meanwhile, are aggressively pursuing Valdez and Suárez, leaving no stone unturned. As for the Padres, they’ll need multiple rotation additions after losing Dylan Cease to free agency and Yu Darvish to injury.
Michael King’s market is a fascinating study in risk versus reward. Will he bounce back to become a dominant starter, or will injuries continue to derail his career? Only time will tell. What’s your take? Is King worth the gamble, or should teams steer clear? Let us know in the comments!
